معرفی
Cécile Tremblay is a Full Professor at the Université de Montréal's Department of Microbiology, Infectious Diseases and Immunology within the Faculty of Medicine. She holds the Pfizer/Université de Montréal Chair in Translational HIV Research and leads the Quebec Public Health Laboratory. Her primary focus is HIV pathogenesis, aging comorbidities, and antiretroviral strategies.
Education: MD from Université de Montréal (1992), postdoctoral training at Massachusetts General Hospital (1997–2000), and extensive certifications in infectious diseases from Canadian and American medical boards.
Research interests span HIV transmission prevention, viral reservoirs, and immune dysfunction. She leads major studies like the Canadian HIV and Aging Cohort and the COVIH study on SARS-CoV-2 in HIV-positive individuals. Key findings include IL-32's role in cardiovascular complications and immune aging markers.
Grants include IRSC-funded projects on endocannabinoid systems in HIV inflammation and HIV prevention strategies. She supervises over 10 PhD/MSc students and collaborates with global teams on reservoirs, vaccine development, and clinical trials.
Labs: Quebec Public Health Laboratory and CHUM's research teams. Active in global HIV conferences (AIDS, CROI) since 1992.
